Housekeeping gene
|
GAPDH
|
Forward, 5′ – ACGATGACATCAAGAAGGTG – 3′
|
180 bp
|
Reverse, 5′ – CATACCAGGAAATGAGCTTG – 3′
|
Pluripotent markers
|
Oct4
|
Forward, 5′ – GGAGTCCCAGGACATCAAAG – 3′
|
285 bp
|
Reverse, 5′ – GCCTGCACAAGTGTCTCTGC – 3′
|
Nanog
|
Forward, 5′ – ACGGATCCAGCTCAGCCCCA – 3′
|
192 bp
|
Reverse, 5′ – GGGGCTGCCCTGAGCAAGTA – 3′
|
Mesenchymal markers
|
CD44
|
Forward, 5′ – TGGGTTGTTTGGCATCCAGTGC – 3′
|
100 bp
|
Reverse, 5′ – CGTTTTCTTCAGTTGGTTCCCAGCC – 3′
|
CD166
|
Forward, 5′ – ACTGGCAGTGGAAGCGTCAT – 3′
|
275 bp
|
Reverse, 5′ – CAGCAAGGAGGAGACCA – 3′
|
CD29
|
Forward, 5′ – GGAAACTTGGTGGCATTGTT – 3′
|
180 bp
|
Reverse, 5′ – GTTCCTTGTAAACGGGCTGA – 3′
|
CD73
|
Forward, 5′ – AGCAAAGGGGCCACTAGCATCT – 3′
|
233 bp
|
Reverse, 5′ – ACCCGAATGTCCCAGTGCAA – 3′
|
CD90
|
Forward, 5′ – GAGCACACGTACCGCTCCCG – 3′
|
233 bp
|
Reverse, 5′ – AGCAGCAGCAGCAGCATCCA – 3′
|
Hematopoietic marker
|
CD34
|
Forward, 5′ – CTTTAACTGTCACGGCGTTT – 3′
|
198 bp
|
Reverse, 5′ – TGACTCGGGAACATTTGATT – 3′
|
Immunological markers
|
MHC-I
|
Forward, 5′ – CATCACCCTGAGATGGGAGC – 3′
|
176 bp
|
Reverse, 5′ – TGGGTACTGTCGTCGCGTG – 3′
|
MHC-II
|
Forward, 5′ – TCCGGAATCAGAAAGGACAC – 3′
|
172 bp
|
Reverse, 5′ – GGCAAACCAAATCCTGAGAA – 3′
|
Osteogenic markers
|
OCN
|
Forward, 5′ – CTGCCTCTGCCTGGCTGGTC – 3′
|
120 bp
|
Reverse,5′ – TAGCGCCGGAGCCTCCTCAC – 3′
|
OPN
|
Forward, 5′ – ACTGGTCACTGATTTTCCCACGGA – 3′
|
100 bp
|
Reverse, 5′– AACCACACTATCACCTCGGCCA – 3′
|
Adipogenic markers
|
ADPQ
|
Forward, 5′ – TGAGAAAGGAGATCCAGGTC – 3′
|
308 bp
|
Reverse, 5′ – TCAAGTAGACTGTGATGTGG – 3′
|
PPAR-γ
|
Forward, 5′ – CATGGTTGACACAGAGATGC – 3′
|
239 bp
|
Reverse, 5′ – GCTCCACTTTGATTGCACTTTG –3′
|
Chondrogenic markers
|
ACAN
|
Forward, 5′ – AAGTGGAGCCGCGTTTCCAAGG – 3′
|
163 bp
|
Reverse, 5′ – AGTCATTGGAGCGCAGGTTCTGG – 3′
|
COL2A1
|
Forward, 5′ – AGTTGGGAGTAATGCAAG – 3′
|
294 bp
|
Reverse, 5′ – GATAACCTCTGTGACCTTTG – 3′
|
Neurogenic marker
|
NES
|
Forward, 5′ – AAACAGGGCCTACAGAG – 3′
|
293 bp
|
|
|
Reverse, 5′ – ACAGGTGTCTCAAGGGTAG – 3′ |
|